A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

NCT07175285 · clinicaltrials.gov ↗

RECRUITING

Status

223

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus (SLE)

Interventions

DRUG: Current standard of care treatment options

Sponsor

Bristol-Myers Squibb